7th April 2021

BSAC is establishing a UK Drug Registry (UKAR) to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where real clinical unmet needs lie. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

UKAR will be a collaborative epidemiological study delivered by BSAC in partnership with Aberdeen University and supported by industry partners. The Registry will initially be open for intravenous antibiotics, with a particular focus on multi-drug resistant organisms.

The registry will be overseen by an expert steering group to ensure appropriate consent and governance at all levels of implementation and will begin data collection by October 2021.

Companies wishing to join the registry and include their antimicrobial agents are invited to contact Tracey Guise, CEO by email.

GP? Pharmacist? Researcher? Social Scientist? Whatever field you work in, if you’re committed to fighting infection then we want you to join us as a BSAC Member.
Become a member
I have read and agree to the Privacy Policy

Having trouble finding what you're after?

Top